CHARLOTTE CASEBOURNE

Co-Founder & Chief Executive Officer, Theolytic

Charlotte believes in equitable access to effective therapies. She is the CEO and Co-founder of Theolytics – a pre-clinical biotech company harnessing viruses to fight cancer – in addition to being a Board Member of the UK Bioindustry Association.

Previously Co-founder and Director of New Medicine Partners, Charlotte has worked with organisations spanning three continents to support the early translation of novel life science technologies. Her personal interests have led her to take leadership roles including Curator of the World Economic Forum Global Shapers network, Managing Director of HealthTech Women London, and HelloTomorrow’s London Chair for Healthcare and Medical Technologies.

Charlotte graduated as a University of Cambridge Bioscience Enterprise M.Phil Scholar and was a shortlisted finalist for Cambridge Entrepreneur of the Year. She was most recently named one of Forbes 30 Under 30, and In Vivo’s 30 Rising Leaders in Life Sciences.